[
1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43 (Suppl.1): S99-S112.
]Search in Google Scholar
[
2. Eckert C, Klein N, Kornek M, Lucas-Kornek V. The complex myeloid network of the liver diverse functional capacity at steady state and in inflammation. Frontiers in Immunology 2015; 6: article 179.
]Search in Google Scholar
[
3. Crispe IN. Immune tolerance in liver disease. Hepatology 2014;60(6):2109-2117.
]Search in Google Scholar
[
4. Rahman AH, Aloman C. Dendritic cells and liver fibrosis. Biochem Biophys Acta 2013; 1832: 998-1004.
]Search in Google Scholar
[
5. Weston CJ, Zimmermann HW, Adams DH. The role of myeloid- derived cells in the progression of liver disease. Frontiers in Immunology 2019; 10: article 893.
]Search in Google Scholar
[
6. Almeda -Valdes P, Aguilar Olivos NE, Barranco-Fragoso B et al. The role of dendritic cells in fibrosis progression in nonalcoholic fatty liver disease. Biomed Res Int 2015, Article ID 768071, 7 pages.
]Search in Google Scholar
[
7. Ueno H, Schmitt N, Klechevsky E et al. Harnessing human dendritic cell subsets for medicine. Immunol Rev 2010; 234(1): 199-212.
]Search in Google Scholar
[
8. Henning JR, Graffeo CS, Rehman A et al. Dendritic cell limit fibro-inflammatory injury in NASH. Hepatology 2013; 58(2): 589-602.
]Search in Google Scholar
[
9. Ibrahim J, Nguyen AH, Rehman A et al. Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver. Gastroenterology 2012; 143(4): 1061-1072.
]Search in Google Scholar
[
10. Strauss O, Dunbar PR, Bartlett A, Philips A. The immunophenotype of antigen-presenting cells of the mononuclear phagocyte system in normal human liver – ‘61 systematic review. J Hepatol 2015; 62(2): 458-468.
]Search in Google Scholar
[
11. Liaskou E, Wilson DV, Oo YH. Innate immune cells in liver inflammation. Mediators of Inflammation. 2012; Article ID 949157, 21 pages.
]Search in Google Scholar
[
12. Adams C, King S, Allgeier T et al. DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 2005; 106(1): 338-344.
]Search in Google Scholar
[
13. Xia S, Guo Z, Xu X et al. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood 2008; 112: 3175-3185.
]Search in Google Scholar
[
14. Hudertmark J, Krenkel O, Tacke F. Adapted immune responses of myeloid-derived cells in fatty liver disease. Frontiers in Immunology 2018; 9: article 2418. Concentrations of lipid regulate tolerance, and immunity in mouse and human liver. Gastroenterology 2012; 143: 1061-1072.
]Search in Google Scholar
[
15. Angel CE, Chen C-J, Horlacher OC et al. Distinctive localization of antigen-presenting cells in human lymph nodes. Blood 2009; 113(6): 1257.
]Search in Google Scholar
[
16. Melly R, Raso GM, Calignano A. Role of innate immune response in non-alcoholic fatty liver disease: metabolic complications and therapeutic tools. Frontiers in Immunology 2014; 5: article 177.
]Search in Google Scholar
[
17. Haniffa M, Shin A, Bigley V et al. Human tissues contain CD- 141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 2012; 37(1): 60-73.
]Search in Google Scholar
[
18. Gulubova M. Myeloid and plasmacytoid dendritic cells and cancer – new insights. Open Access Macedonian Journal of Medical Sciences 2019; 7(19): 3324-3340
]Search in Google Scholar
[
19. Kelly A, Fahey R, Fletcher JM et al. CD141(+) myeloid dendritic cells are enriched in healthy human liver. J Hepatol 2014; 60(1): 135-142.
]Search in Google Scholar
[
20. Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008; 29: 352-361.
]Search in Google Scholar
[
21. Connolly MK, Bedrosian AS, Mallen-St Clair J et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest 2009;119(11):3213-3225.
]Search in Google Scholar
[
22. Sutti S, Locatelli I, Bruzzi S et al. CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis. Clinical Science 2015; 129: 797-808.
]Search in Google Scholar
[
23. Donnelly KL, Smith CI, Schwarzenberg SJ et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1343-1351.
]Search in Google Scholar
[
24. van Herck MA, Weyler J, Kwanten WJ et al. The differential roles of T cells in nonalcoholic fatty liver disease and obesity. Frontiers in Immunology 2019; 10: article 82.
]Search in Google Scholar
[
25. Narayanan S, Surette FA, Hahn YS. The immune landscape in nonalcoholic steatohepatitis. Immune Netw 2016; 16: 147-158.
]Search in Google Scholar
[
26. Reschner A, Hubert P, Delvenne P et al. Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin Exp Immunol 2008; 152: 219-226.
]Search in Google Scholar
[
27. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392(6673): 245-252.
]Search in Google Scholar
[
28. Winer S, Chan Y, Paltser G et al. Normalization of obesityassociated insulin resistance through immunotherapy. Nat Med 2009; 15(8): 921-29.
]Search in Google Scholar
[
29. Vonghia L, Magrone T, Verrijken A et al. Peripheral and hepatic vein cytokine levels in correlation with non-alcoholic fatty liver disease (NAFLD)-related metabolic, histological and hemodynamic features. PLoS ONE 2015a; 10(11): e0143380.
]Search in Google Scholar
[
30. Rau M, Schilling A-K, Meertens J et al. Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17/resting regulatory T cell ratio in peripheral blood and in the liver. J Immunol 2016; 196(1): 97-105.
]Search in Google Scholar
[
31. Van der Weerd K, Dik WA, Schrijver B et al. Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype. Diabetes 2012; 61(2): 401-408.
]Search in Google Scholar
[
32. Chackelevicius CM, Gambaro SE, Tiribelli C, Rosso N. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. World J Gastroenterol 2016; 22(41): 9096-9103.
]Search in Google Scholar
[
33. Tang Y, Bian Z, Zhao L et al. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clin Exp Immunol 2011; 166: 281-290.
]Search in Google Scholar
[
34. Vonghia L, Ruyssers N, Schrijvers D et al. CD4+ RORγt ++ and tregs in a mouse model of diet-induced nonalcoholic steatohepatitis. Mediat Inflam 2015b; 2015: 239623.
]Search in Google Scholar
[
35. Rolla S, Alchera E, Imarisio C et al. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. Clin Sci (Lond) 2016; 130: 193-203.
]Search in Google Scholar
[
36. Zhang JY, Zhang Z, Lin F et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010;51(1):81-91.
]Search in Google Scholar
[
37. Kuang DM, Peng C, Zhao Q et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 2010; 51: 154-164.
]Search in Google Scholar
[
38. Zeng C, Shi X, Zhang B et al. The imbalance of Th17/Th1/ Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl) 2012; 90: 175-186.
]Search in Google Scholar
[
39. Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflammm Bowel Dis 2013; 19: 1772-1788.
]Search in Google Scholar
[
40. He B, Wu L, Xie W et al. The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice. BMC Immunl 2017; 18(1): 33.
]Search in Google Scholar
[
41. Cipolletta D, Feuerer M, Li A et al. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012; 486(7404): 549-553.
]Search in Google Scholar
[
42. Jia L, Wu C. The biology and functions of Th22 cells. Adv Exp Med Biol 2014; 841:209-230.
]Search in Google Scholar
[
43. Fabbrini E, Cella M, McCartney SA et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology 2013; 145(2): 363-366.
]Search in Google Scholar
[
44. Andersen MH, Schrama D, Thor Straten P, Becker JC. Cytotoxic T cells. J Invest Dermatol 2006; 126(1): 32-41.
]Search in Google Scholar
[
45. Wang Y, Tian Z. Gamma delta T cells in liver diseases. Front Med 2018; 2: 262-268.
]Search in Google Scholar
[
46. Bolte FJ, Rehermann B. Mucosal-associated invariant T cells in chronic inflammatory liver disease. Semin Liv Dis 2018; 38: 60-65.
]Search in Google Scholar
[
47. Magalhaes I, Pingris K, Poitou C et al. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest 2015; 125(4): 1752-1762.
]Search in Google Scholar
[
48. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001;106(3): 255-258.
]Search in Google Scholar
